Sevikar HCT 20 mg/5 mg/12.5 mg
Sevikar HCT 20 mg/5 mg/12.5 mg is a medicine authorised by Swissmedic under authorisation number 61519. The authorisation holder is Daiichi Sankyo (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 30 May 2011 and the authorisation is valid without a time limit. ATC code C09DX03 places the medicine in the group Agents acting on the renin-angiotensin system.
| Authorisation number | 61519 |
|---|---|
| Name | Sevikar HCT 20 mg/5 mg/12.5 mg |
| Full name | Sevikar HCT 20 mg/5 mg/12.5 mg, Filmtabletten |
| Authorisation holder | Daiichi Sankyo (Schweiz) AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C09DX03 |
| First authorisation | 30 May 2011 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Sevikar HCT 20 mg/5 mg/12.5 mg, Filmtabletten | B | 30 May 2011 |
| 2 | Sevikar HCT 40 mg/5 mg/12.5 mg, Filmtabletten | B | 30 May 2011 |
| 3 | Sevikar HCT 40 mg/10 mg/12.5 mg, Filmtabletten | B | 30 May 2011 |
| 4 | Sevikar HCT 40 mg/5 mg/25 mg, Filmtabletten | B | 30 May 2011 |
| 5 | Sevikar HCT 40 mg/10 mg/25 mg, Filmtabletten | B | 30 May 2011 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Tablette(n) | C09DX03 | 02.07.2. | B |
| 2 | 98 | Tablette(n) | C09DX03 | 02.07.2. | B |
| 3 | 28 | Tablette(n) | C09DX03 | 02.07.2. | B |
| 4 | 98 | Tablette(n) | C09DX03 | 02.07.2. | B |
| 5 | 28 | Tablette(n) | C09DX03 | 02.07.2. | B |
| 6 | 98 | Tablette(n) | C09DX03 | 02.07.2. | B |
| 7 | 28 | Tablette(n) | C09DX03 | 02.07.2. | B |
| 8 | 98 | Tablette(n) | C09DX03 | 02.07.2. | B |
| 9 | 28 | Tablette(n) | C09DX03 | 02.07.2. | B |
| 10 | 98 | Tablette(n) | C09DX03 | 02.07.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Sevikar HCT 20 mg/5 mg/12.5 mg authorised in Switzerland?
Yes. Sevikar HCT 20 mg/5 mg/12.5 mg is authorised by Swissmedic under authorisation number 61519, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Sevikar HCT 20 mg/5 mg/12.5 mg have?
Sevikar HCT 20 mg/5 mg/12.5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Sevikar HCT 20 mg/5 mg/12.5 mg?
The authorisation holder is Daiichi Sankyo (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.